Matinas BioPharma Holdings Inc (MTNB)
0.6344
-0.08
(-10.65%)
USD |
NYAM |
Nov 14, 16:00
0.6306
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Free Cash Flow: -17.87M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -17.87M |
| March 31, 2024 | -16.96M |
| December 31, 2023 | -15.50M |
| September 30, 2023 | -15.26M |
| June 30, 2023 | -16.04M |
| March 31, 2023 | -18.83M |
| December 31, 2022 | -20.05M |
| September 30, 2022 | -19.70M |
| June 30, 2022 | -20.45M |
| March 31, 2022 | -16.13M |
| December 31, 2021 | -15.48M |
| September 30, 2021 | -15.80M |
| June 30, 2021 | -15.05M |
| March 31, 2021 | -17.35M |
| December 31, 2020 | -17.37M |
| September 30, 2020 | -17.96M |
| June 30, 2020 | -16.88M |
| March 31, 2020 | -16.13M |
| December 31, 2019 | -14.50M |
| September 30, 2019 | -12.22M |
| June 30, 2019 | -10.98M |
| March 31, 2019 | -10.99M |
| Date | Value |
|---|---|
| December 31, 2018 | -10.86M |
| September 30, 2018 | -10.27M |
| June 30, 2018 | -10.18M |
| March 31, 2018 | -12.28M |
| December 31, 2017 | -12.40M |
| September 30, 2017 | -12.48M |
| June 30, 2017 | -11.03M |
| March 31, 2017 | -7.608M |
| December 31, 2016 | -6.119M |
| September 30, 2016 | -5.142M |
| June 30, 2016 | -5.949M |
| March 31, 2016 | -7.106M |
| December 31, 2015 | -7.891M |
| September 30, 2015 | -9.167M |
| June 30, 2015 | -8.635M |
| March 31, 2015 | -8.295M |
| December 31, 2014 | -8.250M |
| September 30, 2014 | -7.566M |
| June 30, 2014 | -6.840M |
| March 31, 2014 | -4.927M |
| December 31, 2013 | -2.988M |
Free Cash Flow Range, Past 5 Years
-20.45M
Minimum
Jun 2022
-14.50M
Maximum
Dec 2019
-17.02M
Average
-16.88M
Median
Jun 2020
Free Cash Flow Benchmarks
| Equillium Inc | -15.77M |
| Tenon Medical Inc | -10.46M |
| Alphatec Holdings Inc | -197.78M |
| Merck & Co Inc | 14.84B |
| Madrigal Pharmaceuticals Inc | -438.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.106M |
| Cash from Investing (Quarterly) | -2.938M |
| Cash from Financing (Quarterly) | 9.189M |
| Free Cash Flow Per Share (Quarterly) | -0.6228 |
| Free Cash Flow Yield | -625.2% |